Within the field of oncology, catecholamines have been demonstrated to stimulate secretion of pro-angiogenic factors such as vascular endothelial growth factor (VEGF) and boost tumor migration in several cancer cell lines [10–12]. The gene discussed is VEGFA; the disease is cancer.